Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis

Affiliations

• ¹ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
• ² University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
• ³ University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
• ⁴ Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "L. Spallanzani" - IRCCS, Rome, Italy.
• ⁵ Unit of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
• ⁶ Dept of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
• ⁷ Educational Institution "Grodno State Medical University", Grodno, Belarus.
• ⁸ Division of Infection, Barts Health NHS Trust, London, UK.
• ⁹ Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
• ¹⁰ National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
• ¹¹ Depts of Pulmonary Diseases and Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
• ¹² University of Groningen, Dept of Pharmacy, Section Pharmacotherapy and Pharmaceutical Care, Groningen, The Netherlands.
• ¹³ WHO Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS, Tradate, Italy.
• ¹⁴ University of Groningen, University Medical Center Groningen, Dept of Internal Medicine - Infectious Diseases, Groningen, The Netherlands.
• ¹⁵ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands [email protected].